![A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis - Kidney International A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7e3b2f5b-a120-4600-8f2a-d8560c7d470e/gr1_lrg.jpg)
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis - Kidney International
![Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial - The Lancet Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f8b29d86-0bee-4fbd-a236-dd470d81b67a/gr1.jpg)
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial - The Lancet
![A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus - Furie - 2011 - Arthritis & Rheumatism - Wiley Online Library A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus - Furie - 2011 - Arthritis & Rheumatism - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a1523976-0ac2-44b7-9f8e-84170f311f55/mfig002.jpg)
A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus - Furie - 2011 - Arthritis & Rheumatism - Wiley Online Library
![Differential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms | Scientific Reports Differential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-31492-5/MediaObjects/41598_2018_31492_Fig1_HTML.png)
Differential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms | Scientific Reports
![Recycling | Free Full-Text | How to Assess Product Performance in the Circular Economy? Proposed Requirements for the Design of a Circularity Measurement Framework | HTML Recycling | Free Full-Text | How to Assess Product Performance in the Circular Economy? Proposed Requirements for the Design of a Circularity Measurement Framework | HTML](https://www.mdpi.com/recycling/recycling-02-00006/article_deploy/html/images/recycling-02-00006-g001b.png)
Recycling | Free Full-Text | How to Assess Product Performance in the Circular Economy? Proposed Requirements for the Design of a Circularity Measurement Framework | HTML
![JRFM | Free Full-Text | An Exploratory Study Based on a Questionnaire Concerning Green and Sustainable Finance, Corporate Social Responsibility, and Performance: Evidence from the Romanian Business Environment | HTML JRFM | Free Full-Text | An Exploratory Study Based on a Questionnaire Concerning Green and Sustainable Finance, Corporate Social Responsibility, and Performance: Evidence from the Romanian Business Environment | HTML](https://www.mdpi.com/jrfm/jrfm-12-00162/article_deploy/html/images/jrfm-12-00162-g0A2.png)
JRFM | Free Full-Text | An Exploratory Study Based on a Questionnaire Concerning Green and Sustainable Finance, Corporate Social Responsibility, and Performance: Evidence from the Romanian Business Environment | HTML
![Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data | medRxiv Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/01/04/2020.12.30.20249034/F2.large.jpg)
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data | medRxiv
![First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial - Journal of Thoracic Oncology First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c0ebcf62-eaf9-48a7-a7d0-0118616e70eb/gr6a_lrg.jpg)
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial - Journal of Thoracic Oncology
![Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates | Cellular & Molecular Immunology Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-021-00809-2/MediaObjects/41423_2021_809_Fig1_HTML.png)